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         Abstract        
 Parkinson’s disease is a neurodegenerative disorder that impairs motor and speech 
skills due to the degeneration of dopamine-producing cells located in the substantia nigra 
portion of the brain.  Currently, a novel treatment involves replacing the lost cells with 
cultivated stems cells that are capable of producing dopamine.  Previous studies 
involving this treatment have complications due to the death of the majority of the 
injected progenitor cells.  It is currently unknown if cell death occurs during delivery or 
after injection.  A neural catheter has been designed that is capable of taking cytometric 
fluorescence-based measurements using a fiber optic probe. This device will allow 
researchers to quantify the number of viable cells delivered.  
 In this study, the original prototype was redesigned in order to be suited for 
animal testing.  A significant reduction of the original cost resulted from fabrication of 
the new design.  A static fixture was built and tested using fluorescent microspheres that 
used the same optic fiber layout as the catheter to ensure the integrity of the 
measurements.  
 In order to deliver a uniform distribution of cells, cell suspension materials are 
required.  Several suspension materials were tested to determine which would provide the 
most uniform distribution of cells in the medium.  The 3RT rat gliomal cell line was used 
as a model for neural cell delivery. A well-plate experiment was designed to determine 
which cell suspension materials supported cell viability.  A separate cuvette experiment 
determined the extent of cell settling issues upon delivery.  Both experiments tested two 
different coating mechanisms; comparing the efficiency of Bovine Serum Album and 
PolyHEMA coatings in preventing cell coagulation upon the walls.  
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               4. Introduction      
 
 Parkinson’s disease is a neurodegenerative disorder which afflicts more than 1 
million Americans at a cost of $25 billion dollars annually [1].  This chronic and 
progressive disease is caused by the degeneration of dopamine producing neurons in the 
substantia nigra, which reduces the production of the neurotransmitter dopamine and the 
number of connections between nerve cells [2].  Dopamine is essential for the 
transmission of nerve impulses to muscles.  The degeneration of these neurons reduces 
the ability of the basal ganglia to smooth out muscle movements, causing the classic 
symptoms of Parkinson’s disease: muscle rigidity, a resting tremor, slowness of voluntary 
movements, and a gradual decline of motor skills [2].     
 The treatment of this disorder is complicated, due to the fact that dopamine is 
unable to cross the brain blood barrier. An option that has emerged in recent years is stem 
cell therapy.  Dopamine-producing stem cells can be injected into the substantia nigra to 
supplement production of dopamine by the deficient neurons.  However, the prospects of 
stem cell therapy in the treatment of Parkinson’s disease are debated.  Past studies have 
showed that the up to 90 % of the injected cells undergo apoptosis [3-6].  It is currently 
unknown if the cell death is due to complications from the injection process or as a result 
of an immune reaction.  In order to determine the viability of the cells upon insertion, a 
cytometric neural catheter has been designed [7].  This device will allow researchers to 
quantify the number of viable cells delivered. 
 
 
 
             5. Problem Statement     .    
 The original prototype of the neural catheter had key issues that needed to be 
addressed by the team, the most significant of which was that it was not biocompatible 
due to material selection.  In order to enable the device to be used for future animal 
testing, the catheter needed to be redesigned to incorporate biocompatible materials. The 
original design cost $1600.00 for the fabrication of two prototypes. An additional goal 
was to be able to fabricate 4-6 prototypes under a $1600.00 budget. This required a 
significant reduction in price per prototype, so the design needed to be rugged but elegant 
enough that available machine shops would be able to fabricate the catheter under budget 
and to needed specification.  
 The cytometric neural catheter uses fiber optic elements incorporated into the tip 
to quantify the cells and determine viability upon delivery.  Past experimentation of the 
prototype proved to have cell settling issues which caused nonuniform delivery, possibly 
resulting in cell death.  The choice of cell suspension material, which lacked the ability to 
consistently suspend the cells over time, was theorized to be the root of the settling 
problem.  One separate project goal was to research and choose a cell suspension material 
which would allow a uniform delivery. This required significant testing of different 
materials to check for cell viability and cell settling. Experiments that tested these issues 
needed to be designed and executed by the team using the researched potential 
suspension materials.  
 This paper discusses the design and calibration of the redesigned catheter. The 
methodology and results for determining the most efficient suspension material is also 
presented. Several cell suspension materials were tested in order to determine which best 
serves the interests of cell delivery.  The two factors that were considered were the ability 
of the material to support the cells physiologically and to provide uniform delivery.   
 
A. Fall Timeline 
Table 1 represents the time allocation for the different aspects of the fall project.  
 Table 1: Gant Chart for Fall 2008 
B. Spring Timeline 
Table 2 represents the time allocation for the different aspects of the spring project.  
 
Table 2: Gant Chart for Spring 2009 
 
            6. Previous Work      
 The original catheter prototype was a modular tip designed to be compatible with 
existing neurosurgical catheters.  The tip incorporates optical fibers for the cytometric 
determination of the number of viable cells exiting the port of the tip.  The prototype was 
fabricated out of common brass and has an outer diameter of 3.2 mm and the exit port is 
0.38 mm in diameter.  The total length of the catheter tip was 12.8 mm.  The tip had the 
optical fiber mount as well as a thin-walled extension.  The extension served to attach a 
multi-lumen tube to the tip which had two cuts in it.  One of the cuts would protect the 
optical fibers upon insertion and delivery and the other would serve to connect to the 
mount.  The schematic of the multi-lumen tube is shown in Appendix 2.  The delivery 
tube would be inserted inside of the multi-lumen tube.  The original pocket for the 
porthole was cut with a mill saw.  A rendered image of the original base is shown in 
Figure 1.  The schematic of the original prototype is in the Appendix 3 [7].   
                                
                               Figure 1: Rendered Image of the Original Base 
 The tip has a series of smooth grooves, designed to assist in the placement of the 
optical fibers.  These grooves allow the self-alignment of five optical fibers.  Two fibers 
were polished at a 45° angle and were coated with a 100 nanometer layer of chromium 
using electron beam evaporation in order to create a reflective surface.  The fibers were 
spaced 0.25 mm apart and attached using an ultraviolet light curing epoxy [7].  The set-
up of the optical fibers is shown in Figure 2.  
 Figure 2: Set-up of Fiber Optic Assembly 
 As shown in Figure 2, the blue fibers act as the light delivery and collection fibers.  
The two 45° polished fibers act as turning mirrors, allowing the excitation beam to enter 
the system by the delivery fiber and exit via the collection fiber.  The alignment grooves 
allow the illumination delivery and the turning fibers to work together so that the 
excitation beam, designed for fluorescence illumination, can be delivered across the exit 
port.  The green fiber, as shown in Figure 2, serves to measures the scatter of the 
excitation beam and the fluorescence within the cell suspension [7].  
 The original experimentation used the RT2 rat gliomal cell line as a neural cell 
delivery model.  The delivery suspension material was Phosphate Buffer Saline (PBS).  
These cells were transfected to express green fluorescent protein (GFP) and are 
designated as 3RT1 cells [8].  As the cells die the expression of GFP halts or dramatically 
decreases [7].  The catheter tip delivers an excitation beam designed to fluoresce GFP.  
The optical fiber set-up measures the fluorescence of the delivery, allowing the 
quantification of cell death due to GFP expression.  Dr. Boyd Evans, III of Oak Ridge 
National Laboratory has applied for a patent for this device.  
 
            7. Catheter Design      
 One of the original goals of the project was to design and fabricate a rugged 
version of the neural catheter tip that could be used in animal testing.  In order to 
accomplish this goal, our team had many issues to address.  There were physical and 
material requirements that needed to be taken into consideration in the design process.  
The design also needed to allow the fabrication of 4-6 prototypes under a $1600.00 
budget, so a significant reduction in cost was required. Design modifications were made 
in order to reduce the complication of the original design and lower the fabrication cost.   
 
A.  Design 
 
 The physical requirements of the design required precisely cut v-edges, all cut to 
the same depth and angle, which would house six optical fibers.  These v-edges needed to 
be the same height as the optic fibers in order to create a flush surface. A port hole would 
be cut at the top of the catheter tip and needed to line up precisely with the middle v-edge 
to ensure accurate cytometric measurements.  This port hole also had to reach the inlet 
hole for delivery. The optical fibers would need to be protected during insertion and 
delivery, so the new design had to encompass this as well. The maximum size allowed 
for the design was a 1/8” diameter with a 1/2” length, to be allowed for future animal 
testing.  The assembly of the testing apparatus needed to be taken into account, so the 
design was modified to ensure ease of assembly. 
 Several initial designs were proposed and drafted (Appendix 1), but many of them 
did not solve all the initial requirements.  Eventually, it was decided that the elimination 
of the extension and the multi-lumen tube would significantly reduce the cost of 
fabrication and also ease the assembly of the full testing apparatus.  The thin-wall 
extension on the previous design was a difficult and costly cut.  This extension served to 
attach the expensive multi-lumen tube, which would protect the fibers.  The use of the 
multi-lumen tube enhanced the complication of the design, due to the fact the tip had to 
be designed with intense restrictions so that the multi-lumen tube would attach to the 
catheter tip (Appendix 2).  It was decided that a bridge material could serve as an 
extension, which would allow the attachment of the delivery tubing.  A cheap and 
biocompatible heat-shrink tube would surround the tip and the optical fibers in order to 
serve as protection against the natural environment.  This significantly reduced the 
fabrication cost and also reduced the size of the assembly.  The schematic of the 
redesigned catheter tip is shown in Figure 2.   The full-rendered image of the redesigned 
tip is shown in Figure 3.      
     Figure 2: Final Design of Catheter Tip 
   
Figure 3 – Full Body Render of Assembly Base 
 
  
 The v-edges that run along the catheter tip were designed to be the same height as 
the optic fibers and needed to be straight cuts. To ensure the cuts were the same height 
and depth, the machine shop that fabricated the catheters needed to have a mill saw. As 
shown in Figure 2, the v-edges were given slight fillet cuts to smooth out the shape cut. 
This would allow the fibers to sink into the v-edge, ensuring they did not extend above 
the catheter.  
 The inlet hole on the catheter for the bridge tube connection was designed to have 
a 1/16” diameter.  This connection between the catheter tip and the bridge connector was 
designed to be push-fit so that an adhesive between the bridge tube connection and the 
catheter would not be required.  This push-fit design was done to lower the difficulty 
when building the full assembly. Another benefit to using a 1/16” diameter between the 
inlet hole and bridge connection was that stock items could be readily purchased instead 
of the need for custom tubing. The schematic of the bridge tubing is shown in Appendix 
4.  The inlet hole was offset from the v-edges equal to the diameter of the fibers to allow 
ease of assembly and to avoid a potential bending of the fibers. A separate supply tube 
that would connect to the other end of the bridge tubing was also designed to be push-fit.  
Luer locks were purchased to allow attachment of the supply tube to the syringe pump. 
The bottom of the catheter tip was given a flat edge in order to increase stability while 
attaching the optic fibers to the v-edges.  
 The porthole was designed to sit in a pocket that would be cut into the top of the 
catheter.  The pocket was cut to the same depth as the v-edges and would ensure that all 
the cells would be counted as they passed through the tip and exited out the porthole. As 
shown in Figure 2, the porthole was designed to be cut as far back as possible into the 
bevel of the inlet cut.  This would serve to prevent the cells from coagulating at the end 
of the inlet hole.  These design modifications were done to help ensure accurate counting 
of cells.  
 Tolerances were important for this device.  It was important that the v-edges were 
of near exact same depth and width to ensure the laser light would travel in the correct 
path.  Due to the small scale of the device, tolerances were designed to be as small as 
possible. A render of the full catheter assembly, including catheter tip, bridge connection 
tube, supply tube, and fiber optics, can be seen in Figure 4.  
. 
Figure 4 – Full Assembly Render: Titanium Catheter, PEEK Bridge Connector Tubing (black), PVC 
Supply Tube (Red), Fiber Optics (yellow) 
 
B. Material Selection  
 Material selection was an important aspect of the design.  There were many 
requirements that the selected material had to meet, among these were: inherent 
biocompatibility, MRI compatibility, machinability, and ease of sterilization.  Through 
much research, it was decided that titanium would prove to be the best base material for 
the catheter tip.   
 The most important requirement is that the material was inherently biocompatible.  
Stem cell treatment was estimated to last between two hours and two weeks [7], so it was 
important to select a material which could remain in vivo for that amount of time without 
causing negative side effects.  Titanium has been shown to be able to remain in vivo for 
up to 26 weeks without causing behavioral changes or neurological deficits [9].  It is also 
important to note that titanium does not require surface treatment for biocompatibility, so 
this choice also reduced costs.    
 Magnetic resonance imaging (MRI) compatibility was also important.  The 
placement of the catheter in the correct region of the brain, the substantia nigra, is 
required for effective treatment.  The material must be able to undergo an MRI scan to 
determine the correct placement of the device.  Titanium is a nonferrous metal, so there is 
not a magnetic attraction in the MRI environment, allowing the metal to undergo an MRI 
scan [10].  Also, there is not a significant heat increase in titanium during an MRI, so 
there would not be any damage to local tissues during the scan [11].  
 Another important thing to note is the creation of artifacts during an MRI.  
Titanium is MRI compatible due to the fact that it is not ferromagnetic, but it is slightly 
paramagnetic, causing the image to read a slight artifact on the scan.  Through research, it 
was determined that the artifact would not interfere in the determination of placement of 
the catheter tip [12, 13].  
 Titanium was also chosen due to ease of machining.  The smooth and precise      
v-edge tolerances were essential to the design and a material was needed that could be 
machined to the design’s strict tolerances.  The design required a specific tool for 
machining the v-edges, a mill saw, and would leave a clean, finished surface after the 
cuts were made. Shular Tools, located in Oak Ridge, Tennessee, had the tools and ability 
to manufacture the device.   
 Polyether-ether-ketone (PEEK), a thermoplastic, was chosen as the material for 
the bridge tubing (Appendix 4).  There were several requirements of the bridge tubing 
that PEEK fulfilled.  The material had to be rigid to allow ease of insertion and also had 
to be inherently biocompatible.  It also needed to be manufactured in thin wall tubes to 
ensure steady flow from the transition of the bridge tubing to the catheter tip. PEEK is 
mass produced as thin-wall tubing in a stock size that fit our design.  This choice of 
material fit all of the requirements of the bridge tubing and was significantly cheaper than 
custom tubing or any other alternative.   
 The delivery tube is a polyvinylchloride (PVC) tube.  This tubing was designed to 
be push-fit as well, easing assembly by fitting to the PEEK connector tube without any 
need of an adhesive.  The heat-shrink tubing was polyolefin.  Both of these materials are 
biocompatible and sold in stock sizes that fit our design.  The titanium tip and the optical 
fibers are able to undergo a low-dose gamma radiation [14, 15].  The polyimide covering 
of the optical fiber has an aromatic group attached to polymer chain, making it resistant 
to low-dose radiation [15].  PEEK must undergo Ethylene Oxide (EtO) sterilization [16].  
The PVC tubing and polyolefin heat shrink tubing will be disposed of after use.  
 
 
 
C. Cost Analysis of Design 
 The new design simplified the original design and made it more efficient.  The 
tips were manufactured out of titanium while utilizing a PEEK bridge connector to fulfill 
the application requirements.  Six prototypes of the tips were fabricated for only $408.00.  
The PEEK tubing cost $26.50 for 25 feet and fifteen feet of PVC and 6 feet of the heat 
shrink tubing totaled $7.50. These items gave a total cost for the design of $442.00 which 
was only a fourth of the catheter budget. The design of catheter is both rugged and ready 
for animal testing and is significantly cheaper than the previous prototype.  
 
                   8. Fabrication of Static and Catheter Fixtures          
 Two different testing fixtures were made: static fixtures and catheter assemblies.  
In order to assemble the fixtures, polished optical fibers were required since a clean 
signal was a necessity for testing.  The fibers were polished at 90˚ and 45˚ angles using 
the Bare Fiber Adapter Kit by Ocean Optics™ and designed hockey-pucks, which are 
shown in Figure 5.   
Figure 5: Hockey-puck 
 Each fiber was polished using three successive sandings: 15 µm, 5µm, and 1 µm 
and viewed using the Clauss Fiber Optic Inspection Microscope™ to determine if the 
fiber was clear.  The 45˚ fibers and the middle fiber were coated with a 100 nanometer 
layer of chromium using electron beam evaporation in order to create a reflective surface.  
The 45˚ fibers were chromed to act as turning mirrors and the middle fiber was chromed 
to enhance the signal.  The light delivery fiber was lined up with the laser in order to pass 
the light to the fixture to excite the microbeads or 3RT1 cells. The collection fiber was 
attached to a computer that collected data using the Ocean Optics OOIbase32 program.  
 
A. Static Fixture 
 The static fixtures were assembled on the back of a Petri dish.  The fibers were 
assembled in accordance to the original catheter fiber optic set-up.  The fibers were 
assembled manually on the Petri dish using a video microscope.  The video microscope 
was also used to confirm the quality of the fibers angles.  The fibers were adhered to the 
Petri dish using a Dura Hold Blocking Compound (Part # KL16050) and cured using an 
ELC-410 Spot Cure System™.  
 Due to sensitivity and accuracy required for the alignment of the fibers, the 
assembly of the static fixtures was time consuming. The alignment of the fibers had to be 
perfect, along with the appropriate rotation of the 45˚ fibers. The first static fixture took 
two weeks to assemble with the last two fixtures taking a week a piece to assemble.  A 
highly magnified image of the static fixture is shown in Figure 6. 
 Figure 6: Static Fixture Under Video Microscope 
B. Catheter Assembly 
 The two catheter assemblies proved much less time consuming than the static 
fixtures. The smooth design of the v-edges allowed easy insertion and rotation of the 
optical fibers, drastically cutting down time of assembly. The catheter set-ups took a day 
each to assemble. These fibers were also adhered to the fixture using a Dura Hold 
Blocking Compound (Part # KL16050) and cured using an ELC-410 Spot Cure System™. 
 
                    9. Calibration Experiment           
 The static fixture was made in order to test and calibrate the fiber-optic layout of 
the titanium catheter.  Microbeads of increasing concentration would be placed on the 
static fixture and fluoresced.  Ideally, a linear relationship between the fluorescent 
intensity and fluorescent concentration should be obtained, proving that the optic-fiber 
set-up is able to successfully measure the concentration of microbeads. 
 
 
 
A. Methods  
 The used microbeads were 10 µm in diameter, approximately the same size as 
neurons. The beads were originally stored in a solution that contained 0.15M NaCl, .05% 
Tween 20, and 0.02% thimerosal. In order to simulate the environment the beads were 
stored in, the experimental solutions that were made contained 99.5 mL of water and 0.5 
mL of Triton X 100, which imitated the detergent Tween 20. Before the solutions were 
made, the beads were vortexed and sonicated to suspend the beads and ensure even 
distribution.  Seven solutions were made with increasing concentration of fluorospheres 
including a blank solution, 10%, 30%, 50%, 70%, 85%, and 100% microbeads.  Each 
concentration was made in 5 mL volumes with 5 µL placed upon the static test fixture to 
take readings.  The laser was set at 477 nm and powered at 4.8 mW.  The experiment was 
run using green fluorescing microbeads, which fluoresced at 515 nm.  
 
B. Results 
 Figure 7 is an image of the static fixture during experimentation.  The microbeads 
were placed on the static fixture and fluoresced.   
 
Figure 7: Static Fixture with Green Fluorescing Microbeads 
 The results of calibration experiments are shown in Figures 8 and 9.  Figure 8 is 
the data obtained from the Ocean Optics OOIbase32 program, showing the intensity 
curve of each of the concentrations.  Figure 9 displays the relationship between the 
intensity at 537.93 nm and the concentration.  
 
Figure 8: Fluorescent Intensity versus Wavelength 
 Figure 9: Fluorescent Intensity at 537.93 nm versus Concentration  
 
C. Discussion 
 Figure 8 shows the fluorescent intensity versus the wavelength.  The peak shown 
at 477 nm is the intensity measured directly from the laser.  The highest fluorescence of 
the green beads is shown at 537.93 nm.  It can be seen here that as the concentration 
increases that the fluorescing intensity does as well. 
 As hypothesized, a linear relationship was obtained between the fluorescing 
intensity at the fluorescing wavelength of the microbeads and the concentration (Figure 
9).  This shows that as the concentration of the microbeads increases, the measured 
intensity increases as well.  Statistical analysis was done to prove linearity; an R2 value of 
0.9655 was obtained.  This relationship shows that the fiber optic layout of the titanium 
catheter can accurately measure fluorescing intensity.  
 
 
                                10. Cell Suspension - Reasons    
 An extensive literature review for suitable media was accomplished in the fall of 
2008.   From the literature six media were determined to be candidates for testing in the 
spring of 2009.  The six media chosen were phosphate buffer saline (PBS), Dulbecco’s 
modified eagle medium (DMEM) without phenol red, varying concentrations of methyl 
cellulose, N-isopropyl acrylamide (NIPPAM), NIPPAM –co-Acrylic Acid (NIPPAM-co-
AAc), and NIPPAM-co-AAc with fibronectin proteins functionalized to the copolymer 
for cell adhesion.  It was determined that the best media to test were PBS, DMEM, and 
methyl cellulose on a basis of availability, expense, and ease of processing.  The 
synthesis of the polymeric media was more expensive and difficult to synthesize. Also, a 
stock pile of polymer would be small and the synthesis of the polymer would take more 
than a day as compared to the hour it took to make the PBS/methyl cellulose gels.   
These original media were first used to determine their efficacy in suspending the 
cells in the first cuvette experiment.  However, from the data received in the first cuvette 
experiment the cells had died within two hours of the experiment.  Because of the cellular 
death the choices of media were modified as to improve the cell viability for the cuvette 
experiment and, ultimately, delivering the cells for in vivo studies.  Combinations of the 
three original media—methyl cellulose, PBS, and DMEM—were made to optimize cell 
viability and suspension.  Methyl cellulose acted to increase the density of the suspension 
material to promote suspension of the cells.  DMEM is a cell growth media which 
promotes proliferation.  It contains all of the essential elements for cell life and has a 
greater density than PBS, but not to a significant degree.  The compositions involving 
DMEM were meant to support cell viability and provide suspension.  In addition to these 
original media selections artificial cerebrospinal fluid (CSF) was also selected as a 
possible option.   
PBS was the media used in the original design for the cell delivery.  The density 
of the cells was greater than the density of PBS, causing the cells to settle in solution. 
Since it was noted the cells settled, PBS was the control media for the new media 
selected.   The media used for the cuvette experiments was the following:  PBS (control), 
DMEM only, artificial CSF, 1% methyl cellulose in PBS by weight, 0.5% methyl 
cellulose in PBS by weight, 1% methyl cellulose in DMEM by weight, 0.5% methyl 
cellulose in DMEM by weight with the intention to find the media that is best suited for 
uniform delivery of cells and cell viability.     
 
    11. Cell Suspension – Well Plate            
 A well-plate experiment was designed and executed to determine viability of 
3RT1 cells in a variety of suspension materials using different coating methods.  After 
the wells were coated, cells were added to the suspension materials in each well.  The 
well-plate was then viewed under an incubated fluorescent microscope, which excited the 
3RT1 cells.  This fluorescence allowed the visual determination of cell viability in the 
given suspension material and coating.   
 
A. Methods  
 Seven suspensions were tested, including: Phosphate Buffer Saline (PBS), 1% 
methyl cellulose in PBS, 0.5% methyl cellulose in PBS, DMEM, 1% methyl cellulose in 
DMEM, 0.5% methyl cellulose in DMEM, and Artificial Cerospinal Fluid (CSF).  All 
DMEM culture media used in the experiments were without phenol red.  Each of these 
solutions was tested with three different coating methods.  One section did not have a 
coating and served as a control.  The other two coatings were polyHEMA and bovine 
serum albumin (BSA).   The 3RT1 cells were incubated at 37ºC with 5 % carbon dioxide 
buffer and fed with phenol red fortified DMEM with 10 % fetal bovine serum.   
 
Figure 10: Well-plate Set-up 
 In order to coat the wells, approximately 25 µL of each coating was added to the 
corresponding well.  After 5 minutes, the BSA was aspirated out of the well.  Similarly, 
the polyHEMA was removed after 30 minutes.  After the coating process, 100 µL of each 
suspension material was added to the wells.  The 3RT1 cells were then added to each 
well in 100 µL amounts to give a 1:1 ratio between the suspension material and cells.  
This entire process was performed in a fume hood to prevent contamination.  
 After the addition of the cells, the well-plate was placed in an incubator for 5 
minutes to allow adequate mixing of the cells and suspension material.  The well-plate 
was then viewed under an incubated Nikon Diaphot 300™ fluorescent microscope and 
images were captured using OpenLab™ software on a laptop. 
 The experiment was performed three times.  The first experiment was executed 
using the following suspension materials: PBS, 1% methyl cellulose in PBS, 0.5% methyl 
cellulose in PBS, and 1% methyl cellulose in DMEM and pure DMEM.  In this 
experiment, only two coating methods were tested: BSA and no coating.  PolyHEMA 
was not included in this experiment due to the fact that it was not available for testing at 
that time.  The second experiment was performed with the same suspension materials, but 
included a 0.5% methyl cellulose in DMEM solution.  PolyHEMA was added as an 
additional coating method in the second experiment.  The third experiment had the same 
experimental set-up as the second experiment, but added artificial CSF as an additional 
suspension material. The well-plate set-up is shown in Figure 10. A similar set-up was 
used for all three experiments.  
 
B. Results 
 
 Altogether, 180 images were taken of well-plate data with the best images from 
each group collected and made into montages shown below.  The first experiment results 
are shown in Figure 11.  The images from top to bottom are PBS, 1% methyl cellulose in 
PBS, 0.5% methyl Cellulose in PBS, 1% methyl cellulose in DMEM and finally pure 
DMEM.  The left column represents the uncoated wells; the right column is the BSA 
coated wells.  
 Figure 11: Experiment 1 Results (Column 1 – No Coating, Column 2 – BSA)/(Row A - PBS, Row B - 1% 
Methyl Cellulose in PBS, Row C - 0.5% Methyl Cellulose in PBS, Row D - 1% Methyl cellulose in 
DMEM, Row E - 0.5% Methyl Cellulose in DMEM, Row F - pure DMEM) 
 
 Figure 12 is the results from well-plate experiment 2. From top to bottom, the 
suspension materials are PBS, 1% methyl cellulose in PBS, 0.5% methyl cellulose in PBS, 
1% methyl cellulose in DMEM, 0.5% methyl cellulose in DMEM, and pure DMEM.  The 
far left column is the untreated wells.  The middle column is the polyHEMA coating, 
while the third column is BSA.  In the first column, there is not an image of the 0.5% 
methyl cellulose in PBS with no coating.  All of the cells had died and there was not a 
good representative image of the well available.  
 Figure 12: Experiment 2 Results (Column 1 – No Coating, Column 2 – PolyHEMA, Column 3 – 
BSA)/(Row A - PBS,  Row B - 1% Methyl Cellulose in PBS, Row C - 0.5% Methyl Cellulose in PBS, Row 
D 1% Methyl cellulose in DMEM, Row E - 0.5% Methyl Cellulose in DMEM, Row F - pure DMEM, Row 
G - artificial CSF) 
 
 Figure 13 is the results from well-plate experiment 3. From top to bottom, the 
suspension materials are PBS, 1% methyl cellulose in PBS, 0.5% Methyl Cellulose in 
PBS, 1% Methyl cellulose in DMEM, 0.5% Methyl Cellulose in DMEM, pure DMEM, 
and artificial CSF.  The far left column is the untreated well.  The middle column is the 
polyHEMA coating, while the third column is BSA.   
 Figure 13: Experiment 3 Results Figure 12: Experiment 2 Results (Column 1 – No Coating, Column 2 – 
PolyHEMA, Column 3 – BSA)/(Row A - PBS,  Row B - 1% Methyl Cellulose in PBS, Row C - 0.5% 
Methyl Cellulose in PBS, Row D 1% Methyl cellulose in DMEM, Row E - 0.5% Methyl Cellulose in 
DMEM, Row F - pure DMEM, Row G - artificial CSF) 
 
 
C. Discussion 
 
 The results from the first experiment are shown in Figure 11.  This was the first 
well-plate experiment and the first opportunity to use Nikon Diaphot 300™ to determine 
cell viability.  The results appear to suggest that each of the solutions support cell 
viability similarly, but this is believed to be misleading.  Due to a time constraint, the 
pictures were taken quickly and did not allow adequate mixing of suspension material 
and the cells.  Also, due to inexperience with the equipment, there is also a significant 
background fluorescence, which misleads the viewer into overestimating the cell viability 
in the suspension material.  Considering the results of experiment 3, which show a 
difference in the cell viability dependant upon the suspension material and coating 
method, these results are believed to be misleading due to the aforementioned reasons. 
 The second run of the experiment also resulted in skewed results (Figure 12).  
During testing, multiple users were utilizing Nikon Diaphot 300™.  This led to the 
incubator being left open during testing and long intervals of time occurred between 
measurements.  Regardless of the skewed results, it was observed that coatings were 
required for viability.  The coatings prevent the cells from clinging to the walls, which 
causes a reduction in cell viability.  This can be seen Figure 12 in the no-coating column.  
It was difficult to capture a good image with the wells that lacked a coating, due to the 
fact the cells gripped to the well-wall.  Also, cell coagulation was observed in the 1% 
methyl cellulose in DMEM solution.  
 By the third experiment, the experimental protocol had been finalized and there 
was no outside interference.  This experiment yielded the best results, due to the fact all 
of the wells were imaged in one setting.  These results are shown in Figure 13.  
Comparatively, all three coating methods of pure PBS show a limited amount of cell 
viability.  It was also noted that the cells initially settled very quickly.  Increasing 
concentrations of methyl cellulose were added to the PBS solutions.  It was hypothesized 
that higher concentrations of methyl cellulose would reduce cell viability due to 
coagulation effects [17].  Experimentally, it was shown that the cells were more viable in 
the 1% methyl cellulose than the 0.5% methyl cellulose solutions.  The 1% methyl 
cellulose solution shows viable and suspended cells.  Suspension can be noted due to the 
cloud effect in the images.  The 0.5% methyl cellulose solutions did not show evidence of 
cell viability.  This is theorized to be due to experimental procedures.  The 1% methyl 
cellulose images were captured before the 0.5% solutions.  It is believed that that the 1% 
solutions were alive due to the fact the images were taken first, but cell death occurred 
shortly after imaging.  Our hypothesis holds true with the increasing concentrations 
methyl cellulose in DMEM.  The 1% methyl cellulose in DMEM solution does not 
support cell viability.  The 0.5% solution keeps the cells viable and also participates in a 
limited amount of suspension.  As the concentration of methyl cellulose increases, cell 
viability decreases due to the coagulation effect [17].  It is also noted that as the 
concentration of DMEM increases in these solution, the cell viability also increases. This 
is due to the nature of DMEM.  This suspension was designed to promote cell growth and 
proliferation, increasing the concentration would provide a more suitable environment for 
the cells, promoting cell viability.  
 The pure DMEM solutions had the best cell viability with all coating methods.  
The solution also shows evidence of suspension.  Artificial CSF also showed cell 
viability, although not as significant as DMEM.  The BSA coating of Artificial CSF had a 
similar viability to the pure DMEM solution.  Artificial CSF promoted cell viability, but 
settled quickly.   
 Image capture proved more difficult with the wells that were not coated.  Coatings 
tended to reduce the amount of cells clinging to the well-plate walls.  Overall, the BSA 
coating method appeared to be the best choice.  This method tended to do the best job in 
keeping the cells off of the well-plate walls, easing image capture.  
 Experimentally, it was determined that cell viability was an issue in the 0.5% 
methyl cellulose in PBS and 1% methyl cellulose in DMEM solutions in all three sets.  
Results suggested that BSA coatings produced better imaging.  In conclusion, it was 
determined that the 1% methyl cellulose in PBS, 0.5% methyl cellulose in DMEM, pure 
DMEM, and Artificial CSF solutions better promoted cell viability.   
 
 
                         12. Cell Suspension - Cuvette                           
 A cuvette experiment was designed in order to test for cell settling in each 
solution.  Each cuvette was prepared with either a BSA or PolyHEMA coating, a given 
concentration of cells, and one of the following suspension materials: PBS, 1% Methyl 
Cellulose in PBS, 0.5% methyl Cellulose in PBS, and 1% methyl cellulose in DMEM, 
0.5% methyl Cellulose in DMEM, pure DMEM, and artificial CSF.  Blanks were also 
made of each suspension material and coating method in order to test for background 
fluorescence.  The cuvettes were placed in CUV – ALL—UV™ four-way cuvette holder 
to be excited with a 477 nm laser and the intensity was measured over time.  The 
experimental set-up can be seen in Figure 14.   
 A decrease in the intensity over time shows that the cells are settling within the 
given suspension material.  After all readings had been made, the solution was agitated in 
order to resuspend the cells, and an additional reading was taken.  This allowed the 
determination of whether the decrease in intensity was due to cell settling or cell death.   
 
A. Methods 
 
 The coating method of the cuvette experiment was similar to the well-plate 
experiment.  BSA and PolyHEMA were added to the cuvettes in 1.5 mL volumes.  After 
5 minutes, the BSA was removed. Similarly, the PolyHEMA was removed after 30 
minutes. Fourteen cuvettes of each coating were prepared; 7 of these cuvettes would 
receive cells, while the other 7 would serve as blanks.  The blanks would serve to check 
for background fluorescence of the suspension material and coating.  The cell volume to 
suspension material ratio was 1:1, each adding 0.75 mL to the final volume of 1.5 mL.  
This was done in order to ensure that the ratio was the same as the well-plate experiment.   
 During testing, the CUV – ALL—UV™  holder was placed on a hot plate in an 
enclosed environment in order provide a suitable environment for the cells.  The 
temperature was monitored throughout experimentation. The cuvette was then excited by 
a 477 nm laser, causing the 3RT1 cells to fluoresce at 512 nm.  In order to prevent 
photobleaching, the laser was only allowed to hit the cuvette for few seconds at each 
measurement. This experiment was run three times. The first experiment had inconsistent 
and unreliable data.  Experimental design modifications were made in order to obtain 
reliable data for the next two experiments. For the second experiment, samples that 
showed signs of settling had data points taken for 20 minutes while samples that did not 
show settling were only measured for 10 minutes.  For the third experiment, all samples 
were run for the full 20 minutes.  For each experiment, a measurement was taken at every 
minute for the first 5 minutes, and then every two minutes after that for 20 minutes.  The 
last measurement of each cuvette was taken after the cells were agitated.  This was done 
to check to see if the change of intensity was due to cell settling or cell death.   
 Figure 14: Image of Cuvette Experiment Set-up. Shown: Laser, Cuvette Holder in Incubator, Data Reader 
 
B. Results 
 As mentioned previously, the first experiment did not yield reliable results.  The 
results of the second experiment are shown in Figures 15 and 16; the results of the third 
experiment are shown in Figure 17 and 18.  Figure 15 and 17 are the intensities of given 
suspension material with a PolyHEMA coating versus the time.  Figure 16 and 18 are the 
intensities of given suspension material with a BSA coating versus the time.   
 Figure 15: Experiment 2 - Suspension Material with PolyHEMA coating: Intensity versus Time  
 
 
Figure 16: Experiment 2 - Suspension Material with BSA Coating: Intensity versus Time 
 Figure 17: Experiment 3 - Suspension Material with PolyHEMA coating: Intensity versus Time 
 
 
Figure 18: Experiment 3 - Suspension Material with BSA coating: Intensity versus Time 
 
C. Discussion 
 As mentioned previously, the first experiment did not yield reliable results.  The 
procedure was modified for the next two experiments in order to create a consistent 
experimental environment.  The cells were given a more suitable environment by 
incubating the CUV – ALL—UV™ set-up.  Agitation was reduced between testing times 
by only testing one sample at a time.   
 An important aspect of the experiment was to identify the suspension materials 
which had background fluorescence.  Knowledge of the background fluorescence would 
be useful when delivering the cells through the neural catheter.  It is important that any 
background fluorescence be accounted for during cell excitation during future 
experimentation.   
 For each suspension material and coating, a blank and a cell sample were tested.  
In both experiments, solutions with DMEM components had background fluorescence.  It 
was also noted that the fluorescence intensity of the DMEM solutions were reduced with 
the PolyHEMA coating in comparison to the BSA coating.  In experiment 3, the 
background fluorescence of the DMEM solutions doubled in comparison to experiment 2.  
A different, shorter light-delivery fiber was used for experiment 3; this is believed to be 
the cause of the increase of fluorescent intensity.  The other suspension materials and 
coatings had neutral fluorescent intensity, similar to the default intensity of the program.  
 Pure PBS and DMEM showed significant settling in all cases.  One exception is 
shown in Figure 16; it is believed that the cells in the PBS solution had died, so there is 
no sign of settling. It was also noted that both coating methods, BSA and PolyHEMA, 
sufficiently kept the cells from attaching to the walls.  
 It was theorized that solutions with a higher concentrations of methyl cellulose 
would act as better suspension materials, due to the property of the compound.  Methyl 
cellulose is significantly denser than PBS, promoting cells to remain suspended within 
the solution.  This hypothesis was supported by experiment 2 and the PolyHEMA coating 
of experiment 3.  Generally, 1% methyl cellulose solutions in PBS and DMEM 
suspended the cells better than the 0.5% methyl cellulose in their respective solutions.  
The only deviation in this trend is shown in Figure 4.  The cell settling in the 1% methyl 
cellulose in PBS solution was not significantly different from 0.5% methyl cellulose in 
PBS.   In both PBS and DMEM solutions, increased concentration of methyl cellulose 
promotes better cell suspension.  The only exception is the methyl cellulose in DMEM 
solutions with a BSA coating from experiment 2.  All concentrations showed similar 
settling issues (Figure 16).   
 Comparing equal concentrations of methyl cellulose, the PBS solutions served as 
better cell suspension materials than DMEM.   This is hypothesized to be due to the 
material properties of the combined solutions.  During experimentation, it was noted that 
the methyl cellulose and PBS solutions acted more as a gel, while methyl cellulose-
DMEM solutions acted more fluid-like.  Gel-like material, such as the methyl cellulose in 
PBS solutions, would better suspend the cells, due to the fact that the cells would have 
difficulty moving freely throughout the solution.  A fluid-like material, such as methyl 
cellulose in DMEM, would allow the cells to settle in solution.   
 In order to ensure that the decrease of intensity was not due to cell death, the last 
data points were agitated.  These points were compared to the original intensity.  If the 
intensity of agitated data points was less than the original intensity, it would suggest that 
the cells were dying in solution.  In each experiment, the agitated intensity was close to 
the original measurement.  In some cases, the agitated intensity was greater than the 
initial intensity.  This suggests that the solutions should initially mixed more thoroughly 
in order to provide a reliable range of data.  
 In general, artificial CSF showed signs of settling.  In the second experiment with 
BSA coating, the artificial CSF was vortexed before the first two data points were taken 
causing a drop in intensity (Figure 16).  After seeing this significant drop, the solutions 
were no longer vortexed.  Overall, the BSA coating of CSF showed a significant amount 
of settling; the CSF with PolyHEMA coating only showed slight signs of settling.  The 
extreme settling of the CSF with BSA coating is believed to be due to the vortexing.  In 
the third experiment, the BSA coating of CSF showed signs of suspension.  The 
PolyHEMA coating showed settling after 10 minutes.  With this data, it is difficult to 
ascertain the degree of settling artificial CSF would undergo, although it does appear that 
it would experience some cell settling.  
 The 1% methyl cellulose in PBS solution appeared to be the best solution to 
prevent cell settling.  Increasing the amount of methyl cellulose in solution appeared to 
decrease the amount of cell settling.  The PBS solutions were better cell suspensions than 
the equivalent DMEM solutions.  The cells settled very quickly in pure PBS and DMEM.  
The cell settling effects of artificial CSF were difficult to determine, but it appears that 
the cells gradually settle.  Coatings were invaluable in reducing the amount of cells on the 
cuvette walls. 
 
                          13. Summary/ Conclusion                           
 All of the goals of this project were successfully completed.  The original 
prototype of the neural catheter was redesigned, allowing the device to be used in future 
animal studies.  The fiber optic layout of the catheter tip was shown to effectively count 
cells.   
 As shown in the well-plate experiments, the presence of DMEM in the solutions 
promoted cell viability.  Pure DMEM appeared to promote cell viability to the greatest 
extent.  However, 1% methyl cellulose in PBS was also shown to be effective in 
promoting cell viability.  It was also determined that coatings are required to sustain cell 
viability. 
The 1% methyl cellulose in PBS provided the most effective suspension material; 
this was displayed in the cuvette experiments.  It is suggested that 1% methyl cellulose in 
PBS would provide the best cell suspension material in terms of viability and effective 
suspension.  The 1% methyl cellulose in PBS solution showed exceptional cell 
suspension properties and was also one of the few solutions able to show cell viability in 
the well-plate experiment. Another benefit is that neither material gives off a fluorescent 
signal when excited by the laser. This will benefit future experiments by providing a 
cleaner signal and easing data analysis.   
 
                                   14. Budget                         
MABE CAPSTONE DESIGN BUDGET 
Mechanical, Aerospace and Biomedical Engineering 
 
Academic Year: 2008/2009   Faculty: Dr. Jack Wasserman 
 
Project Title: Neural Catheter and Cell Suspension Design 
 
Student Names:  
 
Erik Bowman, Brad Meccia, Kaan Serpersu, Jennifer Watson 
 
Project Narrative:                                                                                                                     
                                                                                                                 
The group was tasked with designing and overseeing the fabrication of a neural catheter 
that could eventually be used for animal testing. The requirements for the catheter 
included: biocompatible, MRI compatible, fit the current methods of testing, make the 
assembly process easier, lower fabrication costs, v-grooves for alignment of fiber optics 
to be used in cytometric measurements, less than 1/8 inch diameter, and compatible with 
sterilization methods.  
 
The group was also tasked with researching and selecting the best cell suspension 
medium to be used in the delivery of 3RT1 cells. The cell suspension needed to be 
biocompatible, biodegradable, bioabsorbable, should not allow the cells to settle in the 
bottom of the suspension, and should allow the cells to disperse uniformly though the 
catheter.  
 
The group has finished the design and has had 6 titanium catheters fabricated.  Seven 
cells suspensions were chosen and their effect on cell viability and effectiveness of 
suspending the cells has been determined.   
 
 
Budget: 
a) Supplies (brief description and usage)  
 
PBS ($35.40), Dulbecco minimal eagle medium ($21.50), Acrylic acid ($79.57), 
Isopropylacryamide ($209.57) – All used as potential cell suspensions 
 
Catheter tips (6) - $408, the designed catheter fabricated from Shular Tools  
 
PEEK tubing 25ft ($26.50), PVC 15ft and Heat Shrink tubing 6ft ($7.50), Leur 
Locks (12) ($5.00) – All used in final assembly with the catheters. The PEEK 
tubing serves as a bridge between the catheter and the PVC tube, with the heat 
shrink tubing being used to secure all pieces together. The Leur locks are places at 
the opposite end and used to inject the 3RT1 cells through the PVC into the 
catheter.  
 
Optical Fiber - $60, attached to the catheter in 6 places, with two being cut at 45 
degrees. Will pass a laser through where the strength will be measured by a 
computer.  
 
Epoxy adhesive - $31.55, used to attach the optical fibers to the catheters. UV 
light source needed to cure.  
 
Polishing Paper - $15, before being attached to the catheters all 6 of the fibers 
need to be polished in order for a clear signal to be measured.  
 
Bare Fiber Adapter Kit - $262, this kit was needed in order to hold the fibers in 
place for polishing. 
 
Clauss Fiber Optic Inspection Microscope - $239.97, microscope used to check to 
see if the fiber was fully polished.  
 
Fluorospheres - $230, before 3RT1 cells are used in testing, these fluorospheres 
are used in order to calibrate the testing apparatus.  
 
Total Amount: $1631.56 
 
b) Student Travel  
 
Purpose: To go to ORNL to build and test the catheter assemblies and test cell   
suspension materials in Dr. Boyd Evans’s labs 
 Where: ORNL 
 When:  Fall – Once a week for each member at least 
              Spring – Every Tuesday, Thursday, and Friday.  
 How many traveling: On Tuesday and Thursday – 3 students, Friday – 2 students.  
 
Total Amount: $400 for both Fall and Spring 
 
c) Equipment ($1,000 and up purchase; <$1,000 per item goes under Supplies)  
  
Description & Purpose: 
 
 ELC-410 Spot Cure System, $935 a UV light source used to cure the UV epoxy. 
 
 CUV – ALL—UV, $1047 – Cuvette Holder 
 
Video microscope - $2000, the fibers are about 250 microns in diameters. The 
microscope was needed in order to build the apparatuses, check fiber quality, and 
check laser route.  
 
 Nikon Diaphot 300™ - $7600 Microscope with image capturing capabilities   
 
Total Amount: $11,942.00  
 
d) Software (must be specific) 
     Ocean optics usp 2000 $199 – used in testing to measure signal strength 
     Mechanical Desktop 2008 student version, $0.00 – used to design catheter  
     OpenLab – Image capturing program, came with Nikon Diaphot  
       
 
Total Amount: $199 
 
e) Others (brief description) 
 Purpose: 
 
Total Amount: $0.00 
 
TOTAL BUDGET AMOUNT:    $14,172. 56 
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     18. Standards                   
ASTM F701 - 81(2008) Standard Practice for Care and Handling of Neurosurgical 
Implants and Instruments 
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Biomedical Application 
 
ASTM D2851 - 98(2004) Standard Specification for Liquid Optical Adhesive 
 
 
